Diabetes Mellitus, Type 2 - Physiopathology
Research News and Information

Saturday, November 21, 2009

Effect of 12-week tai chi chuan exercise on peripheral nerve modulation in patients with type 2 diabetes mellitus.

30 Oct 2009 OBJECTIVE: To examine the effect of tai chi chuan exercise on peripheral nerve modulation in patients with type 2 diabetes mellitus. DESIGN: Parallel group comparative study with a pre- and post- design. SUBJECTS: Twenty-eight participants with ... Read more...

Impaired skeletal muscle beta-adrenergic activation and lipolysis are associated with whole-body insulin resistance in rats bred for low intrinsic exercise capacity.

7 Oct 2009 Rats selectively bred for high endurance running capacity (HCR) have higher insulin sensitivity and improved metabolic health compared with those bred for low endurance capacity (LCR). We investigated several skeletal muscle characteristics, in ... Read more...

Pharmacotherapy of hyperglycemia.

29 Sep 2009 Type 2 diabetes mellitus (T2DM) is a chronic, progressive disorder that affects more than 230 million people worldwide and is expected to affect 366 million by 2030. Both the prevalence of T2DM and the cost of its long term complications has driven ... Read more...

Latest indexed articles for 'Diabetes Mellitus, Type 2 - Physiopathology'

These are the very latest articles for this heading:

• Effect of 12-week tai chi chuan exercise on peripheral nerve modulation in patients with type 2 diabetes mellitus. 30 Oct 2009
• Impaired skeletal muscle beta-adrenergic activation and lipolysis are associated with whole-body insulin resistance in rats bred for low intrinsic exercise capacity. 7 Oct 2009
• Pharmacotherapy of hyperglycemia. 29 Sep 2009
• Dapagliflozin: where does it fit in the treatment of type 2 diabetes? 29 Sep 2009
• Abnormal hepatic energy homeostasis in type 2 diabetes. 29 Sep 2009
• Role of renin-angiotensin system blockade in patients with diabetes mellitus. 13 Sep 2009
• Quality of care of diabetes mellitus type II patients in Iran. 30 Aug 2009
• Metabolic syndrome in pediatrics: old concepts revised, new concepts discussed. 30 Aug 2009
• Type 2 diabetes: where we are today: an overview of disease burden, current treatments, and treatment strategies. 30 Aug 2009
• Type 2 diabetes: epidemiology and treatment, pathophysiology, new therapeutics, and the evolving role of the pharmacist. 30 Aug 2009
• Differential chemistry (structure), mechanism of action, and pharmacology of GLP-1 receptor agonists and DPP-4 inhibitors. 30 Aug 2009
• Fate of the beta-cell in the pathophysiology of type 2 diabetes. 30 Aug 2009
• Reversing bacteria-induced vitamin D receptor dysfunction is key to autoimmune disease. 30 Aug 2009
• Mechanisms of insulin resistance assessed by dynamic in-vivo positron emission tomography imaging. 30 Aug 2009
• A novel function of intestinal gluconeogenesis: central signaling in glucose and energy homeostasis. 30 Aug 2009
• Correlation between pancreatic microcirculation and type 2 diabetes in patients with coronary artery disease: dynamic contrast-enhanced MR imaging. 30 Aug 2009
• Influence of duration of diabetes, glycemic control, and traditional cardiovascular risk factors on early atherosclerotic vascular changes in adolescents and young adults with type 2 diabetes mellitus. 30 Aug 2009
• Understanding the nature of metabolic syndrome components in children and what they can and cannot do to predict adult disease. 30 Aug 2009
• Prolonged juvenile States and delay of cardiovascular and metabolic risk factors: the Fels Longitudinal study. 30 Aug 2009
• Comment on: Perry et al. (2009) interrogating type 2 diabetes genome-wide association data using a biological pathway-based approach. Diabetes;58:1463-1467. 30 Aug 2009

See a longer list of these articles.

Technical information about 'Diabetes Mellitus, Type 2'

Definition: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.

Descriptor UI: D003924

Alternative terms: Diabetes Mellitus, Type 2; Diabetes Mellitus, Ketosis-Resistant; Diabetes Mellitus, Ketosis Resistant; Ketosis-Resistant Diabetes Mellitus; Diabetes Mellitus, Maturity-Onset; Diabetes Mellitus, Maturity Onset; Diabetes Mellitus, Non Insulin Dependent; Diabetes Mellitus, Non-Insulin-Dependent; Non-Insulin-Dependent Diabetes Mellitus; Type 2 Diabetes Mellitus; Diabetes Mellitus, Slow-Onset; Diabetes Mellitus, Slow Onset; Slow-Onset Diabetes Mellitus; Diabetes Mellitus, Stable; Stable Diabetes Mellitus; Diabetes Mellitus, Type II; Maturity-Onset Diabetes Mellitus; Maturity Onset Diabetes Mellitus; MODY; NIDDM; Diabetes Mellitus, Adult-Onset; Adult-Onset Diabetes Mellitus; Diabetes Mellitus, Adult Onset; Diabetes Mellitus, Noninsulin Dependent;

Related Mesh Headings: Rats, Inbred OLETF; Metabolic Syndrome X;

Allowable Qualifiers: blood; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; surgery; therapy; urine; veterinary; ultrasonography; virology;

Tree Number: C18.452.394.750.149; C19.246.300;

History Note: 2005 (1984)